Stock data

望隼 (4771)

望隼 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$394.53M, up 24.9% from a year earlier. EPS over the last four quarters totals NT$15.21.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 望隼 in Insightr